Saturday 17 October 2026 Export SCL’s income statement to Excel — free account

Stepan Company

Stepan Company’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.96% from fiscal 2024. In the quarter to June 2026, revenue grew 15.0%, EPS grew 100.0%, free cash flow fell 4.42% and total debt fell 1.62%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.

62.03 0.16 +0.26%

Follow SCL

Alert me

Market cap: $1.4B
P/E: 0.0×
Fwd P/E: 2,564×
Dividend yield: 2.55%
F-score: 5/9
Altman Z: 2.54
Beneish M: −2.66
Dividend safety: 65/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 5.66%

Capital & Financial Ratios $m

Market Cap 1,410.00

Revenue 2,432.79

Net Income (2.65)

Free Cash Flow 63.17

Net Debt 533.65

Current Ratio 1.15

Debt/Equity 0.53

P/E ratio 0.00

Fwd P/E 2,564.00

P/S ratio 0.58

P/B ratio 1.17

Past 5Y EPS Growth (17.76%)

This Y EPS Growth 47.80%

Next Y EPS Growth 37.17%

Next Y revenue growth 8.57%

Next 5Y EPS Growth 28.24%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 13.23%

10-year low 10-year high

P/B against its own 10 years 13.34%

10-year low 10-year high

EV/Sales against its own 10 years 12.57%

10-year low 10-year high

EV/FCF against its own 10 years 69.58%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate 1.58

Annual Dividend Yield 2.55%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	1.60	0.40 0.40 0.40
2025	1.55	0.39 0.39 0.39 0.40
2024	1.51	0.38 0.38 0.38 0.39
2023	1.47	0.37 0.37 0.37 0.38
2022	1.74	0.34 0.34 0.34 0.37 0.37
2021	1.25	0.31 0.31 0.31 0.34
2020	1.13	0.28 0.28 0.28 0.31
2019	1.03	0.25 0.25 0.25 0.28
2018	0.93	0.23 0.23 0.23 0.25
2017	0.84	0.21 0.21 0.21 0.23
2016	0.78	0.19 0.19 0.19 0.21

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	130	100	133	114
Receivables	422	388	388	492
Inventory	266	289	299	324
Other	34	34	39	44
	852	810	859	975

	2023	2024	2025	Q'26
Payables	233	259	262	322
ST’ Debt	253	293	286	403
Other	—	—	—	—
	608	669	666	847

Compound Annual Growth %

	10y	5y	3y
Sales	2.76%	4.52%	(5.61%)
Cash Flow	(2.15%)	(8.86%)	(2.75%)
Earnings	(4.71%)	(18.04%)	(31.70%)
Book Value	8.34%	4.71%	2.18%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	605	684	—	—	—
’25	593	595	590	554	2,332
’24	551	556	547	526	2,180
’23	651	580	562	532	2,326
’22	675	752	719	627	2,773
’21	538	596	603	610	2,346
’20	450	461	464	495	1,870

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	17	8	—	—	—
’25	7	11	70	60	148
’24	42	30	23	68	162
’23	(72)	108	70	69	175
’22	(21)	59	37	86	161
’21	(12)	36	(3)	51	72
’20	(6)	65	83	94	235

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(14)	(15)	—	—	—
’25	(26)	(14)	40	52	52
’24	11	0	(4)	32	39
’23	(164)	40	16	22	(85)
’22	(81)	(10)	(39)	(10)	(141)
’21	(53)	(1)	(44)	(24)	(122)
’20	(42)	44	53	53	107

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.81)	1.00	—	—	—
’25	0.86	0.50	0.47	0.22	2.05
’24	0.61	0.42	1.03	0.15	2.20
’23	0.70	0.55	0.55	(0.05)	1.75
’22	1.93	2.26	1.71	0.47	6.38
’21	1.74	1.85	1.59	0.73	5.92
’20	1.18	1.54	1.43	1.30	5.45

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	41.42	68.51	68.09	72.11	69.33	109.08	91.64	63.60	63.77	41.82	Analyst estimates 2026–2028 Powerpack
	High	87.00	92.97	90.96	102.96	129.62	139.30	126.24	114.49	95.33	65.90
People
People	Employees	2,145	2,096	2,250	2,284	2,293	2,439	2,453	2,389	2,396	2,328
	Revenue/emp, $m	0.82	0.92	0.89	0.81	0.82	0.96	1.13	0.97	0.91	1.00
Income, $m
Income, $m	Revenue	1,766	1,925	1,994	1,859	1,870	2,346	2,773	2,326	2,180	2,332
	Gross margin, %	19.21	17.98	17.02	18.28	20.52	16.87	15.40	11.94	12.49	11.57
	EBT	114	147	138	126	171	173	189	48	60	60
	EBT margin, %	6.44	7.63	6.91	6.77	9.15	7.35	6.80	2.08	2.77	2.57
	Net income	86	101	111	103	128	138	147	40	50	47
	Depreciation	75	79	81	79	82	91	95	105	112	126
Per share, $
Per share, $	Revenue	77.49	83.89	86.61	80.63	81.47	102.35	121.74	102.11	95.49	101.96
	Earnings	3.78	3.99	4.90	4.47	5.52	6.01	6.46	1.77	2.21	2.05
	Cash flow	9.31	8.67	7.43	9.47	10.25	3.15	7.06	7.68	7.10	6.47
	Capex	(4.52)	(3.43)	(3.76)	(4.58)	(5.57)	(8.46)	(13.24)	(11.43)	(5.38)	(4.19)
	Free cash flow	4.79	5.24	3.67	4.90	4.68	(5.31)	(6.18)	(3.75)	1.72	2.27
	Book value	27.90	32.29	35.10	38.71	43.07	46.86	51.19	53.41	51.24	54.39
	Shares, m	23	23	23	23	23	23	23	23	23	23
Valuation, ×
Valuation, ×	P/E	21.75	18.22	15.13	22.92	21.58	20.68	16.12	52.79	29.28	23.10
	P/S	1.04	0.95	0.85	1.27	1.46	1.21	0.86	0.92	0.68	0.46
	P/B	2.89	2.47	2.11	2.65	2.77	2.65	2.03	1.75	1.26	0.87
	EV/Sales	1.09	0.95	0.84	1.22	1.38	1.30	1.00	1.14	0.92	0.68
	EV/FCF	17.19	14.76	19.14	19.54	23.38	(25.78)	(20.26)	(32.27)	47.09	28.56
Cash, $m
Cash, $m	Operating cash flow	212	199	171	218	235	72	161	175	162	148
	Capex	(103)	(79)	(87)	(106)	(128)	(194)	(302)	(260)	(123)	(96)
	Free cash flow	109	120	84	113	107	(122)	(141)	(85)	39	52
Balance, $m
Balance, $m	Working capital	388	468	495	480	489	413	374	244	141	192
	Total debt	317	291	276	222	199	364	587	654	625	627
	Net debt	91	(8)	(24)	(93)	(151)	204	413	524	526	494
	Shareholders’ equity	636	741	808	892	988	1,074	1,166	1,216	1,170	1,244
Returns, %
Returns, %	ROA	6.65	7.14	7.44	6.67	7.61	7.22	6.54	1.68	2.16	2.01
	ROIC	10.99	13.21	11.90	9.95	12.81	8.35	8.20	2.10	2.60	2.82
	ROE	14.43	14.64	14.35	12.13	13.48	13.36	13.14	3.37	4.22	3.89

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
NGVT Ingevity Corporation	$2.4B	45.3×	18.5×	−5.25% (below 0%: shrinking)	n/m	−136.08% (below 0%: shrinking)	44.25%	19.13%	Compare
IOSP Innospec Inc.	$2.4B	19.7×	16.3×	+11.76% (above 0%: growing)	+32.98% (above 0%: growing)	−63.16% (below 0%: shrinking)	28.14%	8.08%	Compare
MTX Minerals Technologies Inc.	$2.0B	— (loss-making)	12.4×	+3.69% (above 0%: growing)	n/m	+5.92% (above 0%: growing)	24.40%	(40.17%)	Compare
CC The Chemours Company	$1.9B	— (loss-making)	16.9×	−1.49% (below 0%: shrinking)	n/m	+128.00% (above 0%: growing)	17.98%	(13.39%)	Compare
SCL Stepan Company	$1.4B	— (loss-making)	2,564×	+15.04% (above 0%: growing)	+100.00% (above 0%: growing)	−4.42% (below 0%: shrinking)	14.61%	5.44%
ECVT Ecovyst Inc.	$1.1B	— (loss-making)	18.2×	+41.97% (above 0%: growing)	+40.00% (above 0%: growing)	−66.55% (below 0%: shrinking)	19.94%	7.75%	Compare
ODC Oil-Dri Corporation Of America	$1.1B	18.3×	37.5×	+3.26% (above 0%: growing)	+8.03% (above 0%: growing)	−20.76% (below 0%: shrinking)	27.83%	14.11%	Compare
KRO Kronos Worldwide Inc	$851.7M	— (loss-making)	— (loss-making)	+12.88% (above 0%: growing)	n/m	+291.58% (above 0%: growing)	18.42%	6.74%	Compare
KOP Koppers Holdings Inc.	$821.5M	— (loss-making)	583×	+3.03% (above 0%: growing)	n/m	−2.84% (below 0%: shrinking)	20.96%	(31.92%)	Compare
Median of peers	$1.5B	19.7×	18.2×	+3.48%	+32.98%	−11.80%	22.68%	7.25%

All 60 Specialty Chemicals stocks →

Stepan Company (SCL) key facts

Strength: Stepan Company’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.96% from fiscal 2024.
Stepan Company (SCL) is a Specialty Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
As of October 16, 2026, SCL traded at $62.03, a market capitalization of $1.4 billion.
Stepan Company pays an annual dividend of $1.58 per share, a yield of 2.55%.
Return on equity was 3.89% and debt-to-equity 0.53.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 2.54 (grey zone) for fiscal 2025.